Recent Finacing
Recent Raise
ArcoScreen develops ArcoFlow, a microfluidic GPCR screening platform that assays drug mode‑of‑action on patient primary cells in a single in‑vitro test, identifying GPCR‑activating molecules within minutes.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at ArcoScreen.
